SARS-CoV-2 B Epitope-Guided Neoantigen NanoVaccines Enhance Tumor-Specific CD4/CD8 T Cell Immunity Through B Cell Antigen Presentation
C. Li, S. Mao, Z. Montemayor, M. D. M. Traore, A. Duran, F. Ke, M. Djibo, H. Wen, W. Gao, D. Sun
This study develops a neoantigen vaccine using SARS-CoV-2 B cell epitopes to enhance CD4/CD8 T cell immunity through B cell antigen presentation, showing improved efficacy in multiple cancer models.
bioRxiv · Jul 18, 2024Immunology